Canada markets open in 8 hours 4 minutes

Brainstorm Cell Therapeutics Inc (GHDN.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.4310+0.0260 (+6.42%)
At close: 05:20PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
11,499
13,956
15,235
22,329
Selling General and Administrative
10,051
10,866
9,304
9,355
Total Operating Expenses
21,550
24,822
24,539
31,684
Operating Income or Loss
-21,550
-24,822
-24,539
-31,684
Income Before Tax
-16,632
-24,277
-24,457
-31,811
Income from Continuing Operations
-16,632
-24,277
-24,457
-31,811
Net Income
-16,632
-24,277
-24,457
-31,811
Net Income available to common shareholders
-16,632
-24,277
-24,457
-31,811
Basic EPS
-0.42
-0.66
-0.68
-1.07
Diluted EPS
-0.42
-0.66
-0.68
-1.07
Basic Average Shares
39,346
36,509
36,182
29,848
Diluted Average Shares
39,346
36,509
36,182
29,848